Urinary fatty acid binding protein 3 (uFABP3) is a potential biomarker for peripheral arterial disease

por Abdelrahman Zamzam, Muzammil H. Syed, John Harlock, John Eikelboom, Krishna K. Singh, Rawand Abdin, Mohammad Qadura
Publicado 2021

Systematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.

por Luciane Cruz Lopes, Frederick A Spencer, Ignacio Neumann, Matthew Ventresca, Shanil Ebrahim, Qi Zhou, Neera Bhatnagar, Sam Schulman, John Eikelboom, Gordon Guyatt
Publicado 2014

Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.

por Bader Alsuwailem, Abdelrahman Zamzam, Muzammil H Syed, Elisa Greco, Mark Wheatcroft, Charles de Mestral, Mohammed Al-Omran, John Harlock, John Eikelboom, Krishna K Singh, Rawand Abdin, Mohammad Qadura
Publicado 2021

2020 Asian Pacific Society of Cardiology Consensus Recommendations on Antithrombotic Management for High-risk Chronic Coronary Syndrome

por Jack Wei Chieh Tan, Derek P Chew, David Brieger, John Eikelboom, Gilles Montalescot, Junya Ako, Byeong-Keuk Kim, David KL Quek, Sarah J Aitken, Clara K Chow, Sok Chour, Hung Fat Tse, Upendra Kaul, Isman Firdaus, Takashi Kubo, Boon Wah Liew, Tze Tec Chong, Kenny YK Sin, Hung-I Yeh, Wacin Buddhari, Narathip Chunhamaneewat, Faisal Hasan, Keith AA Fox, Quang Ngoc Nguyen, Sidney TH Lo
Publicado 2021